UNITE-DMD - UK gene therapy trial

In March 2017, Action Duchenne announced our funding of “UNITE-DMD”, one of the first gene therapy trials for Duchenne muscular dystrophy here in the UK.

Expand

ScOT-DMD bone health study

Dr Shuko Joseph has been awarded the funds for a three-year project to better understand bone deterioration in the 2,500 children and young people living with Duchenne muscular dystrophy in the UK.

Expand

Set-up fund for adult Duchenne trials

To enable Ros Quinlivan and her team at the University College London to fund researchers so that trials can continue to run for adults.

Expand

Validating outcome measures

A novel device called ActiMyo® has been proposed for its use as an outcome measure in ambulant and non-ambulant Duchenne trials.

Expand

Repurposed Cancer Therapeutics

Repurposed Cancer Therapeutics as Treatments for DMD, the project will be led by Professor Steve Winder in the Department of Biomedical Science at the University of Sheffield.

Expand

Stem cell therapies

In 2018 we combined forces with Barts Charity to support research into new stem cell therapies for Duchenne

Expand